Default company panoramic image
4158398f 3a18 4745 8400 377dc95d844c

BioSensis

Biosensis sells novel reagents, which are essential to drug research. We will leverage our success through product development and acquisitions.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Thebarton, SA, Australia
  • Currency AUD
  • Employees 4
  • Website biosensis.com

Company Summary

The Company has formulated a plan to; 1) increase the market penetration of existing products into North America, 2) rapidly expand the product portfolio with quality reagents targeted to some of the fastest growing areas of research and 3) execute an acquisition strategy to create a high-value company with revenues in excess of $25 million.

Team

  • Default avatar
    Robert Rush
    Chair

  • Default avatar
    Lyndon Foster
    CEO

  • Default avatar
    Carol Birmingham
    COO

  • Default avatar
    Brian Conn
    CFO

Advisors

  • Default avatar
    Bray-Chan P/L
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Neubody Pty Ltd as Parent Company
    Unconfirmed